Pharma Major Lupin announced that Lupin Pharmaceuticals, its U.S. subsidiary, has launched niacin extended-release tablets USP in 500-mg, 750-mg and 1,000-mg strengths.
Anglo-Swedish drug maker AstraZeneca will buy Omthera Pharmaceuticals for $323 million, the two companies said.
Mylan has launched a generic drug for treating cholesterol, the company said.
Mylan has begun shipping a generic drug for cholesterol, the company said Monday.
Lupin Pharmaceuticals has launched a generic drug for cholesterol disorders, the company said.
The Food and Drug Administration has approved a generic drug for lipid disorders made by Mylan, the company said Friday.